Skip Navigation LinksHome > November 2013 - Volume 29 - Issue 11 > Subcutaneous and Perineural Botulinum Toxin Type A For Neuro...
Clinical Journal of Pain:
doi: 10.1097/AJP.0b013e31827eafff
Review Articles

Subcutaneous and Perineural Botulinum Toxin Type A For Neuropathic Pain: A Descriptive Review

Fabregat, Gustavo MD*; De Andrés, José MD, PhD, FIPP; Villanueva-Pérez, Vicente L. MD*; Asensio-Samper, Juan M. MD*

Collapse Box


Objective: Botulinum toxin is a neurotoxin that has been widely used in chronic pain for the treatment of multiple conditions with a component of localized muscle spasm. Recent studies suggest that botulinum toxin is effective in the treatment of neuropathic pain syndromes such as postherpetic neuralgia or painful scars.

Methods: We searched the PubMed and OvidSP databases. We also included cross-referencing bibliographies from primary and review articles.

Discussion: In this descriptive review, we evaluate the usefulness, safety, and potential pathophysiological mechanism of botulinum toxin type A for treatment of painful disorders with neuropathic component such as postherpetic neuralgia, diabetic neuropathy, or trigeminal neuralgia.

Conclusions: On the basis of the analysis of the reports published in the literature, it would seem that fractioned peripheral subcutaneous and perineural injections of botulinum toxin type A may be useful for the treatment of various chronic pain conditions with neuropathic component.

© 2013 by Lippincott Williams & Wilkins

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.